• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随访丢失对囊性纤维化患者生存估计的影响。

Impact of loss to follow-up on survival estimation for cystic fibrosis.

机构信息

Clinical Affairs, Cystic Fibrosis Foundation, Bethesda, MD.

Clinical Affairs, Cystic Fibrosis Foundation, Bethesda, MD.

出版信息

Ann Epidemiol. 2023 Oct;86:98-103.e5. doi: 10.1016/j.annepidem.2023.07.008. Epub 2023 Aug 6.

DOI:10.1016/j.annepidem.2023.07.008
PMID:37549758
Abstract

PURPOSE

Deaths among those lost to follow-up (LTFU) in the Cystic Fibrosis Foundation Patient Registry (CFFPR) are critically important to the epidemiology of cystic fibrosis (CF). Unreported deaths could impact estimates of survival if LTFU is associated with disease trajectory.

METHODS

We characterized the LTFU population (1986-2017) from the CFFPR and identified deaths via linkage with the National Death Index (NDI). Median predicted survival age and conditional survival were estimated with and without additional deaths and person-time from the NDI.

RESULTS

Of the 10,582 individuals LTFU in the CFFPR, 2,460 (23.2%) matched to an NDI death record. Individuals who died after LTFU with a CF diagnosis were 43% female, 91% White/non-Hispanic, 59% had advanced CF lung disease based on last CFFPR recorded forced expiratory volume in one second (FEV) %predicted <40 and 18% were post-lung transplant. Median predicted survival age during the most recent period available, 2013-2017, increased from 44.3 years (95% CI: 43.2, 45.7) to 45.8 years (95% CI 44.5, 47.1) with the inclusion of NDI data.

CONCLUSIONS

Inclusion of deaths and additional person-time among those LTFU changed the point estimate of median predicted survival for most time periods and increased the point estimate from 2009 onwards.

摘要

目的

在囊性纤维化基金会患者注册中心(CFFPR)中,随访丢失(LTFU)人群的死亡情况对囊性纤维化(CF)的流行病学至关重要。如果 LTFU 与疾病轨迹相关,未报告的死亡可能会影响生存估计。

方法

我们从 CFFPR 中描述了 LTFU 人群(1986-2017 年),并通过与国家死亡指数(NDI)的链接确定了死亡情况。在没有来自 NDI 的额外死亡和人时的情况下,估计了带有和不带有额外死亡和人时的中位预测生存年龄和条件生存。

结果

在 CFFPR 中 LTFU 的 10582 人中,有 2460 人(23.2%)与 NDI 死亡记录相匹配。在 LTFU 后死亡且患有 CF 诊断的个体中,43%为女性,91%为白种人/非西班牙裔,59%的个体最后一次 CFFPR 记录的用力呼气量占预计值的百分比(FEV)%预测值<40%,18%为肺移植后。在最近可用的时间段,即 2013-2017 年,中位预测生存年龄从 44.3 岁(95%CI:43.2,45.7)增加到 45.8 岁(95%CI:44.5,47.1),包括了 NDI 数据。

结论

纳入 LTFU 人群中的死亡和额外的人时数据改变了中位预测生存的点估计,并且从 2009 年开始增加了点估计。

相似文献

1
Impact of loss to follow-up on survival estimation for cystic fibrosis.随访丢失对囊性纤维化患者生存估计的影响。
Ann Epidemiol. 2023 Oct;86:98-103.e5. doi: 10.1016/j.annepidem.2023.07.008. Epub 2023 Aug 6.
2
Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020.2020 年美国囊性纤维化的患病率和参与囊性纤维化基金会患者登记处的情况。
J Cyst Fibros. 2023 May;22(3):436-442. doi: 10.1016/j.jcf.2023.02.009. Epub 2023 Mar 13.
3
Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.美国囊性纤维化基金会患者注册中心的研究表明,囊性纤维化护理中的差距与肺功能下降有关。
Ann Am Thorac Soc. 2023 Sep;20(9):1250-1257. doi: 10.1513/AnnalsATS.202211-951OC.
4
The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.囊性纤维化基金会患者登记处。一个国家观察性疾病登记处的设计与方法。
Ann Am Thorac Soc. 2016 Jul;13(7):1173-9. doi: 10.1513/AnnalsATS.201511-781OC.
5
[Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].[意大利囊性纤维化注册机构(ICFR)。2017 - 2018年报告]
Epidemiol Prev. 2021 May-Jun;45(3 Suppl 1):1-37. doi: 10.19191/EP21.3.S1.050.
6
Lung Function Decline in Cystic Fibrosis: Impact of Data Availability and Modeling Strategies on Clinical Interpretations.肺功能在囊性纤维化中的下降:数据可用性和建模策略对临床解释的影响。
Ann Am Thorac Soc. 2023 Jul;20(7):958-968. doi: 10.1513/AnnalsATS.202209-829OC.
7
[Italian Cystic Fibrosis Register - Report 2010].[意大利囊性纤维化登记处——2010年报告]
Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074.
8
[Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].[意大利囊性纤维化注册机构(ICFR)。2015 - 2016年报告]
Epidemiol Prev. 2019 Jul-Aug;43(4S1):1-36. doi: 10.19191/EP19.4.S1.067.
9
[Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].[意大利囊性纤维化登记处(ICFR)。2019 - 2020年报告]
Epidemiol Prev. 2022 Jul-Aug;46(4 Suppl 2):1-38. doi: 10.19191/EP22.4S2.060.
10
[Italian Cystic Fibrosis Registry. Report 2011-2014].[意大利囊性纤维化注册中心。2011 - 2014年报告]
Epidemiol Prev. 2018 Jan-Feb;42(1S1):1-32. doi: 10.19191/EP18.1-S1.P001.001.

引用本文的文献

1
Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis.CFTR调节剂对囊性纤维化患者长期生存及死亡率的影响:综述与二次分析
Pulm Ther. 2025 Jul 11. doi: 10.1007/s41030-025-00303-4.
2
Linkage of the CF Foundation Patient Registry with the Scientific Registry of Transplant Recipients database.囊性纤维化基金会患者登记处与移植受者科学登记处数据库的关联。
J Cyst Fibros. 2025 Jan;24(1):112-117. doi: 10.1016/j.jcf.2024.09.015. Epub 2024 Oct 2.
3
Development of a Web App to Enhance Physical Activity in People With Cystic Fibrosis: Co-Design and Acceptability Evaluation by Patients and Health Professionals.
开发一款用于增强囊性纤维化患者身体活动的网络应用程序:患者与健康专业人员的协同设计及可接受性评估
JMIR Form Res. 2024 Jul 30;8:e54322. doi: 10.2196/54322.
4
Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020.2020 年美国囊性纤维化的患病率和参与囊性纤维化基金会患者登记处的情况。
J Cyst Fibros. 2023 May;22(3):436-442. doi: 10.1016/j.jcf.2023.02.009. Epub 2023 Mar 13.